Brief: Nasdaq Determines Transcode Therapeutics Compliance With Minimum Stockholders’ Equity Requirement And Continued Listing
31/01/2024 22:33
Jan 31 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* NASDAQ DETERMINES TRANSCODE THERAPEUTICS COMPLIANCE WITH
MINIMUM
STOCKHOLDERS’ EQUITY REQUIREMENT AND CONTINUED LISTING ON THE
NASDAQ STOCK MARKET
Source text for Eikon: ID:nGNX5lV5BQ
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors